Hydrogen sulfide: a candidate multitarget ligand for cardiovascular diseases


YETİK ANACAK G. , SEVİN G. , ERAÇ Y.

Second WG Meeting COST ACTION CA15135, Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig), Tenerife, Spain, 15 March 2018, pp.10

  • Publication Type: Conference Paper / Full Text
  • City: Tenerife
  • Country: Spain
  • Page Numbers: pp.10